UHRF2 and intestinal cancer: Further study revealed that Uhrf2 could bind and SUMOylate TCF4, an important transcription factor downstream of the Wnt signaling pathway, thus stabilizing TCF4 expression and activating Wnt signaling, and finally Uhrf2 promoted the progression of intestinal cancer.